Loading...
XSHE002144
Market cap253mUSD
Dec 25, Last price  
10.47CNY
1D
-1.23%
1Q
12.58%
Jan 2017
-53.71%
IPO
-67.58%
Name

Hongda High-Tech Holding Co Ltd

Chart & Performance

D1W1MN
XSHE:002144 chart
P/E
22.50
P/S
3.46
EPS
0.47
Div Yield, %
0.96%
Shrs. gr., 5y
-0.35%
Rev. gr., 5y
-3.47%
Revenues
535m
-7.63%
201,101,438187,912,970338,951,222352,131,779302,546,229298,377,653409,467,457587,782,215628,716,491585,872,264545,115,309526,648,974569,692,355634,755,297638,464,743543,319,831461,677,366601,036,760579,374,030535,183,326
Net income
82m
+3.22%
28,937,41212,350,20622,839,04920,929,8706,943,12111,239,46140,097,23569,994,660114,718,97981,200,219117,522,009124,793,877100,812,17696,547,56190,848,42882,527,81463,951,71164,866,46479,684,52182,253,031
CFO
75m
-8.58%
35,139,37712,892,92139,984,21211,484,69863,846,89251,287,623166,295,131096,407,55080,550,579118,942,75840,385,838138,963,106147,874,69836,273,065124,780,70388,291,794108,013,10582,286,51875,228,177
Dividend
Jun 20, 20240.15 CNY/sh
Earnings
May 28, 2025

Profile

Hongda High-Tech Holding Co.,Ltd. engages in warp-knitting, medical device, trading, and financial investment businesses in China. It offers automotive interior fabrics, and clothing fabrics. The company also provides medical device products for liver, gallbladder, spleen, kidney, pancreas, heart, thyroid, breast, bladder, uterus attachment, and other organs. It exports its automotive interior fabrics to the United States, Germany, Japan, and internationally. The company was formerly known as Zhejiang Hongda Warp Knitting Co., Ltd. and changed its name to Hongda High-Tech Holding Co.,Ltd. in August 2010. Hongda High-Tech Holding Co.,Ltd. was founded in 1985 and is based in Haining, China.
URL
http://www.zjhongda.com.cn/
IPO date
Aug 03, 2007
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
535,183
-7.63%
579,374
-3.60%
601,037
30.19%
Cost of revenue
424,801
467,861
512,592
Unusual Expense (Income)
NOPBT
110,382
111,513
88,445
NOPBT Margin
20.63%
19.25%
14.72%
Operating Taxes
7,853
8,157
5,639
Tax Rate
7.11%
7.31%
6.38%
NOPAT
102,529
103,356
82,806
Net income
82,253
3.22%
79,685
22.84%
64,866
1.43%
Dividends
(17,676)
(17,676)
(17,676)
Dividend yield
0.87%
0.99%
0.99%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
9,779
393
421
Long-term debt
376
333
1,130
Deferred revenue
13,342
14,552
17,189
Other long-term liabilities
1
1,300
Net debt
(1,237,393)
(1,243,673)
(1,080,656)
Cash flow
Cash from operating activities
75,228
82,287
108,013
CAPEX
(22,171)
Cash from investing activities
(96,626)
55,987
28,421
Cash from financing activities
(9,146)
FCF
39,594
124,288
7,283
Balance
Cash
577,980
546,053
460,418
Long term investments
669,568
698,346
621,789
Excess cash
1,220,788
1,215,431
1,052,155
Stockholders' equity
1,021,154
1,256,693
1,168,004
Invested Capital
1,003,398
738,401
819,945
ROIC
11.77%
13.26%
10.13%
ROCE
5.41%
5.65%
4.69%
EV
Common stock shares outstanding
175,006
176,763
176,763
Price
11.62
15.05%
10.10
-0.30%
10.13
-20.24%
Market cap
2,033,575
13.91%
1,785,302
-0.30%
1,790,604
-20.24%
EV
801,123
546,499
713,345
EBITDA
145,088
147,414
121,420
EV/EBITDA
5.52
3.71
5.87
Interest
1,738
30
88
Interest/NOPBT
1.57%
0.03%
0.10%